Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG Protocol 093)

Mark A. Jacobson, Michael Wulfsohn, Judith E. Feinbergt, Roger Davis, Maureen Power, Susan Owens, Dennis Causey, Margo E. Heath-Chiozzi, Robert L. Murphy, Tony W. Cheung, Douglas T. Dieterich, Stephen A. Spector, George F. McKinley, David M. Parenti, Clyde Crumpacker

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG Protocol 093)'. Together they form a unique fingerprint.

Medicine & Life Sciences